To live and lead with Arête—striving to live everyday with integrity as the best version of myself.
🌇 I'm currently living in Boston, MA 🇺🇸 <> Seoul 🇰🇷 at the intersection of healthcare, humanities, and tech.
Danny Kim, PharmD, Head of WELT USA, is a pharmacist by training and a builder at heart, powered by the mission to democratize healthcare through technologies that improve access to quality care.
With WELT Team Members
Together with his team at WELT, Danny is leveraging the company's consumer-tech DNA to create consumer-friendly digital therapeutics designed to restore balance in the three pillars of life—eating, sleeping, and exercising.
Presenting at DTx East with DiME, FDA, HBS, Abbott
Presenting/Chairing at the Inaugural DTx Asia in Seoul
The go-to-leader for digital therapeutics in the APAC region, Danny was elected to serve as a Board Member Digital Therapeutics Alliance's Board of Directors. He also serves as an advisor to the Korean government on matters involving digital health and digital therapeutics.
With DTA Team at HLTH 2022
Before joining WELT, Danny worked with PillPack (acq. by Amazon), Pear Therapeutics (IPO '21), and invested in early-stage startups with Contrary. Danny continues to invest in early-stage healthcare companies through the Digital Health Partners, Korea's first venture fund dedicated to digital health, as an LP and an advisor.
At Northeastern University Board of Trustees Retreat
Danny is a proud Bostonian and holds a B.S. Pharmacy Studies & Doctor of Pharmacy (PharmD) at Northeastern University where he serves as a Board Member at Health Sciences Entrepreneurs Program and a member of Young Global Leaders.
Danny Kim_Speaker Introduction
Blog | I usually write about conversations, life lessons, and random topics on Medium
가끔, 한국어로 글을 쓸 때도 있습니다:)
In 2017, I founded ViTAL (previously, Bouvé Innovators), Northeastern's first healthcare innovation hub bringing together students from diverse backgrounds (business, health sciences, engineering, design, public policy, and more) to push the boundaries of healthcare innovation.